Having a Coffee Break: The Impact of Caffeine Consumption on Microglia-Mediated Inflammation in Neurodegenerative Diseases
Caffeine is the major component of coffee and the most consumed psychostimulant in the world and at nontoxic doses acts as a nonselective adenosine receptor antagonist. Epidemiological evidence suggests that caffeine consumption reduces the risk of several neurological and neurodegenerative diseases...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2017/4761081 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832552976106913792 |
---|---|
author | Maria H. Madeira Raquel Boia António F. Ambrósio Ana R. Santiago |
author_facet | Maria H. Madeira Raquel Boia António F. Ambrósio Ana R. Santiago |
author_sort | Maria H. Madeira |
collection | DOAJ |
description | Caffeine is the major component of coffee and the most consumed psychostimulant in the world and at nontoxic doses acts as a nonselective adenosine receptor antagonist. Epidemiological evidence suggests that caffeine consumption reduces the risk of several neurological and neurodegenerative diseases. However, despite the beneficial effects of caffeine consumption in human health and behaviour, the mechanisms by which it impacts the pathophysiology of neurodegenerative diseases still remain to be clarified. A promising hypothesis is that caffeine controls microglia-mediated neuroinflammatory response associated with the majority of neurodegenerative conditions. Accordingly, it has been already described that the modulation of adenosine receptors, namely, the A2A receptor, affords neuroprotection through the control of microglia reactivity and neuroinflammation. In this review, we will summarize the main effects of caffeine in the modulation of neuroinflammation in neurodegenerative diseases. |
format | Article |
id | doaj-art-4696d15c52ab49be8526cba3d46c5613 |
institution | Kabale University |
issn | 0962-9351 1466-1861 |
language | English |
publishDate | 2017-01-01 |
publisher | Wiley |
record_format | Article |
series | Mediators of Inflammation |
spelling | doaj-art-4696d15c52ab49be8526cba3d46c56132025-02-03T05:57:11ZengWileyMediators of Inflammation0962-93511466-18612017-01-01201710.1155/2017/47610814761081Having a Coffee Break: The Impact of Caffeine Consumption on Microglia-Mediated Inflammation in Neurodegenerative DiseasesMaria H. Madeira0Raquel Boia1António F. Ambrósio2Ana R. Santiago3Institute for Biomedical Imaging and Life Sciences (IBILI), Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, PortugalInstitute for Biomedical Imaging and Life Sciences (IBILI), Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, PortugalInstitute for Biomedical Imaging and Life Sciences (IBILI), Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, PortugalInstitute for Biomedical Imaging and Life Sciences (IBILI), Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, PortugalCaffeine is the major component of coffee and the most consumed psychostimulant in the world and at nontoxic doses acts as a nonselective adenosine receptor antagonist. Epidemiological evidence suggests that caffeine consumption reduces the risk of several neurological and neurodegenerative diseases. However, despite the beneficial effects of caffeine consumption in human health and behaviour, the mechanisms by which it impacts the pathophysiology of neurodegenerative diseases still remain to be clarified. A promising hypothesis is that caffeine controls microglia-mediated neuroinflammatory response associated with the majority of neurodegenerative conditions. Accordingly, it has been already described that the modulation of adenosine receptors, namely, the A2A receptor, affords neuroprotection through the control of microglia reactivity and neuroinflammation. In this review, we will summarize the main effects of caffeine in the modulation of neuroinflammation in neurodegenerative diseases.http://dx.doi.org/10.1155/2017/4761081 |
spellingShingle | Maria H. Madeira Raquel Boia António F. Ambrósio Ana R. Santiago Having a Coffee Break: The Impact of Caffeine Consumption on Microglia-Mediated Inflammation in Neurodegenerative Diseases Mediators of Inflammation |
title | Having a Coffee Break: The Impact of Caffeine Consumption on Microglia-Mediated Inflammation in Neurodegenerative Diseases |
title_full | Having a Coffee Break: The Impact of Caffeine Consumption on Microglia-Mediated Inflammation in Neurodegenerative Diseases |
title_fullStr | Having a Coffee Break: The Impact of Caffeine Consumption on Microglia-Mediated Inflammation in Neurodegenerative Diseases |
title_full_unstemmed | Having a Coffee Break: The Impact of Caffeine Consumption on Microglia-Mediated Inflammation in Neurodegenerative Diseases |
title_short | Having a Coffee Break: The Impact of Caffeine Consumption on Microglia-Mediated Inflammation in Neurodegenerative Diseases |
title_sort | having a coffee break the impact of caffeine consumption on microglia mediated inflammation in neurodegenerative diseases |
url | http://dx.doi.org/10.1155/2017/4761081 |
work_keys_str_mv | AT mariahmadeira havingacoffeebreaktheimpactofcaffeineconsumptiononmicrogliamediatedinflammationinneurodegenerativediseases AT raquelboia havingacoffeebreaktheimpactofcaffeineconsumptiononmicrogliamediatedinflammationinneurodegenerativediseases AT antoniofambrosio havingacoffeebreaktheimpactofcaffeineconsumptiononmicrogliamediatedinflammationinneurodegenerativediseases AT anarsantiago havingacoffeebreaktheimpactofcaffeineconsumptiononmicrogliamediatedinflammationinneurodegenerativediseases |